Literature DB >> 20482520

Antinuclear autoantibodies in women with recurrent pregnancy loss.

Carlo Ticconi1, Federica Rotondi, Manuela Veglia, Adalgisa Pietropolli, Sergio Bernardini, Francesco Ria, Alessandro Caruso, Nicoletta Di Simone.   

Abstract

PROBLEM: To investigate the possibility that antinuclear antibodies (ANA) are involved in recurrent pregnancy loss (RPL).
METHODS: Case-control study carried out on 294 women (194 cases and 100 controls) in two University hospitals. The presence, the serum titers and the indirect immunofluorescence (IIF) patterns of ANA were determined in women with RPL and in control women.
RESULTS: Antinuclear antibodies at titers ≥ 1:80 were detected in 97 (50%) women with RPL and in 16 (16%) control women. Elevated ANA titers (≥1:180) were detected only in RPL women, whereas all control women had ANA titers no greater than 1:80. No differences could be detected in the IIF patterns between RPL and control women. No differences in ANA positivity could be detected according to the type (primary or secondary) or number (>2 versus ≥3) of losses.
CONCLUSIONS: ANA could be of some value in identifying women with RPL with potential, although still not fully defined, immune abnormalities.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482520     DOI: 10.1111/j.1600-0897.2010.00863.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  16 in total

1.  Pregnancy-associated systemic lupus erythematosus.

Authors:  Rahime Nida Ergin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-07

2.  Plasma level of mannose-binding lectin is associated with the risk of recurrent pregnancy loss but not pregnancy outcome after the diagnosis.

Authors:  C Nørgaard-Pedersen; L H Rom; R Steffensen; U S Kesmodel; O B Christiansen
Journal:  Hum Reprod Open       Date:  2022-06-07

3.  Excess female siblings and male fetal loss in families with systemic lupus erythematosus.

Authors:  Rachna Aggarwal; Andrea L Sestak; Eliza F Chakravarty; John B Harley; R Hal Scofield
Journal:  J Rheumatol       Date:  2013-02-01       Impact factor: 4.666

4.  Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study.

Authors:  Xinyi Li; Xiaoli Deng; Hongji Duan; Lin Zeng; Jiansuo Zhou; Chang Liu; Xiaoyue Guo; Xiangyuan Liu
Journal:  Clin Rheumatol       Date:  2020-06-08       Impact factor: 2.980

Review 5.  Immunogenetic contributions to recurrent pregnancy loss.

Authors:  Frances Grimstad; Sacha Krieg
Journal:  J Assist Reprod Genet       Date:  2016-05-12       Impact factor: 3.357

6.  Uterine blood flow indices, antinuclear autoantibodies and unexplained recurrent miscarriage.

Authors:  A Pietropolli; Valentina Bruno; M V Capogna; S Bernardini; E Piccione; C Ticconi
Journal:  Obstet Gynecol Sci       Date:  2015-11-16

7.  Impacts of Anti-dsDNA Antibody on In Vitro Fertilization-Embryo Transfer and Frozen-Thawed Embryo Transfer.

Authors:  Jiao Fan; Yiping Zhong; Cuina Chen
Journal:  J Immunol Res       Date:  2017-04-28       Impact factor: 4.818

Review 8.  Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines.

Authors:  Nayoung Sung; Ae Ra Han; Chan Woo Park; Dong Wook Park; Joon Cheol Park; Na Young Kim; Kyung Sil Lim; Ji Eun Shin; Chang Woo Joo; Seung Eun Lee; Jae Won Kim; Sung Ki Lee
Journal:  Clin Exp Reprod Med       Date:  2017-03-31

9.  A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment.

Authors:  Qing Zhu; Li Wu; Bo Xu; Mei-Hong Hu; Xian-Hong Tong; Jing-Juan Ji; Yu-Sheng Liu
Journal:  Reprod Biol Endocrinol       Date:  2013-10-05       Impact factor: 5.211

10.  Caesarean section in a case of systemic lupus erythematosus.

Authors:  Varsha Vyas; Deepika Shukla; Surekha Patil; Shubha Mohite
Journal:  Indian J Anaesth       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.